¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-03-09

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-03-09
±³À°ÀÏÀÚ : 2024-03-09
±³À°Àå¼Ò : ´ëÀüÄÁº¥¼Ç¼¾ÅÍ

±³À°ÁÖÁ¦ : 2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇÑ°©»ó¼±ÇÐȸ
´ã´çÀÚ : ÀÌÀçÀº
¿¬¶ôó : 02-743-0320  

À̸ÞÀÏ : office@thyroid.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, À̺ñÀÎÈÄ°ú, ¿µ»óÀÇÇаú, º´¸®°ú, ÇÙÀÇÇаú

Âü¼®¿¹»óÀÎ : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 11 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 120,000¿ø  

ºñ°í " 1. Àü¹®ÀÇ/ÀϹÝÀÇ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 90,000¿ø, ÇöÀåµî·Ï 110,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 100,000¿ø, ÇöÀåµî·Ï 120,000¿ø 2. Àü°øÀÇ/±ºÀÇ°ü/°øÁߺ¸°ÇÀÇ/°£È£»ç/±âÃÊÀÇÇÐÀÚ 1) Æò»ýȸ¿ø ¹× Á¤È¸¿ø(¿¬È¸ºñ ³³ºÎÀÚ) »çÀüµî·Ï 50,000¿ø, ÇöÀåµî·Ï 70,000¿ø, 2) ºñȸ¿ø »çÀüµî·Ï 70,000¿ø, ÇöÀåµî·Ï 90,000¿ø 3. ¸¸65¼¼ ÀÌ»óÀÎ Æò»ýȸ¿ø, Çкλý ¹× ÀÇÀü¿ø Çлý : ¹«·á"


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 08:30~08:50 Clinical risk factors and risk stratification À̵¿±Ù(µ¿¾ÆÀÇ´ë À̺ñÀÎÈÄ°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 08:50~09:10 Imaging- based diagnosis and risk stratification À̹ΰæ(°¡Å縯ÀÇ´ë ¿µ»óÀÇÇаú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 09:10~09:30 Interventional management of recurrent thyroid cancer ¹éÁ¤È¯(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 09:30~09:40 Discussion ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 09:40~10:00 Recent results from the MAeSTro Study compared to prospective cohort studies in other countries ¹®ÀçÈÆ(¼­¿ïÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 10:00~10:20 Protocols of guidelines and prospective studies on AS of low risk PTC ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 10:20~10:40 Standardized imaging for thyroid ultrasound in AS of low risk thyroid cancer: KSThR consensus statement ÀÌÁö¿¹(¼­¿ïÀÇ´ë ¿µ»óÀÇÇаú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 10:40~10:50 Discussion ( )

ÈÞ½Ä 03¿ù 09ÀÏ 201È£ 10:50~11:10 Coffee Break ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 11:10~12:10 Genome editing and medicine ±èÇü¹ü(¿¬¼¼ÀÇ´ë ¾à¸®Çб³½Ç)

±âŸ 03¿ù 09ÀÏ 201È£ 12:10~12:30 ÃÑȸ ( )

½Ä»ç 03¿ù 09ÀÏ 201È£ 12:30~13:20 Lunch ( )

Åä·Ð 03¿ù 09ÀÏ 201È£ 13:20~14:20 ÆгÎÅäÀÇ ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 14:20~15:00 How to minimize the complications of the thyroid surgery ÀÌ°­´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú)

ÈÞ½Ä 03¿ù 09ÀÏ 201È£ 15:00~15:20 Coffee Break ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 15:20~15:50 Organoids in thyroid gland À¯¹ÎÈñ(¾ÈÀü¼ºÆò°¡¿¬±¸¼Ò)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 15:50~16:20 Epigenomic analysis in thyroid cancer ±è¶ô±Õ(¿¬¼¼ÀÇ´ë ÀÇ»ý¸í°øÇаú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 16:20~16:30 Discussion ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 16:30~16:55 2024³â ´ëÇÑ°©»ó¼±ÇÐȸ °©»ó¼±¾Ï Áø·á±Ç°í¾È ÀÌÀº°æ(±¹¸³¾Ï¼¾ÅÍ ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 16:55~17:20 ÆгÎÅäÀÇ ÀÓµ¿ÁØ ³ªµ¿±Ô ±èÁ¤ÇÑ ±¸º»¼® Á¤Âù±Ç ÀÌ»ó¿ì(°¡Å縯ÀÇ´ë ³»°ú °­¸ª¾Æ»êº´¿ø ¿µ»óÀÇÇаú ¼º±Õ°üÀÇ´ë ¿Ü°ú Ãæ³²ÀÇ´ë À̺ñÀÎÈÄ°ú °¡Å縯ÀÇ´ë º´¸®°ú °æºÏÀÇ´ë ÇÙÀÇÇаú)

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 17:20~17:30 ÀúÀ§Ç豺 °©»ó¼±¾ÏÀÇ Ä¡·á ¹æħ¿¡ ´ëÇÑ KTA ¼³¹®°á°ú ±è¹ÎÁÖ(¼­¿ïÀÇ´ë ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 17:30~17:40 Discussion ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 201È£ 17:40~17:50 °©»ó¼±±â´ÉÇ×ÁøÁõÀÇ ¹æ»ç¼º¿ä¿ÀµåÄ¡·á ±Ç°í¾È ±è°æÁø(°í·ÁÀÇ´ë ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 201È£ 17:50~18:00 Discussion ( )

±âŸ 03¿ù 09ÀÏ 201È£ 18:00~18:10 ½Ã»ó½Ä ¹× Closing Remark ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 08:30~08:40 [±¸¿¬¹ßÇ¥] Ultrasound-Guided Thrombin Injection for the treatment of choice for iatrogenic thyroid pseudoaneurysm "ÇÔÅÂÇõ (¼­¿ï´ëÇб³º´¿ø ¿µ»óÀÇÇаú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 08:40~08:50 [±¸¿¬¹ßÇ¥] Cost-effectiveness of diagnosis by ultrasound for asymptomatic thyroid cancer in South Korea "Á¤È£Áß (°­³²¼¼ºê¶õ½ºº´¿ø ¿Ü°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 08:50~09:00 [±¸¿¬¹ßÇ¥] Intraoperative Neuromonitoring During Thyroidectomy Does Not Decrease Vocal Cord Palsy Risk, but Cumulative Experience May "¿À¹®¿µ (¼­¿ïƯº°½Ãº¸¶ó¸Åº´¿ø ¿Ü°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:00~09:10 [±¸¿¬¹ßÇ¥] Association between M2 macrophage infiltrations and radioactive iodine sensitivity in thyroid cancer "ÀÌÀÚ°æ (ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¿Ü°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:10~09:20 [±¸¿¬¹ßÇ¥] Continuous intraoperative nerve monitoring in thyroidectomy using automatic periodic stimulation: preliminary case series "¹èÁØÇü (ºÐ´ç¼­¿ï´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:20~09:30 [±¸¿¬¹ßÇ¥] ´ëÇѵΰæºÎ¿Ü°úÇÐȸ °©»ó¼±¾Ï °ËÁø ¹× Ä¡·á µ¿Çâ ´ëȸ¿ø Á¶»ç º¸°í "±èÁö¿ø (ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú)"

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 09:40~10:00 °©»ó¼± ¼ö¼úÀÇ Á¾·ù¿Í ÀÔ¿øȯÀÚ ÄɾîÀÇ ÁÖÀÇÁ¡ ÇãÁØ(¿¬¼¼ÀÇ´ë ¿Ü°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 10:00~10:20 °©»ó¼± ¾àÁ¦ÀÇ Ã³¹æ ¹× º¹¿ë ¿ä·É ¼ÛÀÇ¿¬(°í·ÁÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 10:20~10:40 ¹æ»ç¼º ¿ä¿Àµå Ä¡·á ÈÄ È¯ÀÚ ÄÉ¾î ¹Ú¼ÒÇö(±¹¸³¾Ï¼¾ÅÍ ÇÙÀÇÇаú)

Åä·Ð 03¿ù 09ÀÏ 204,5È£ 10:40~10:50 Discussion ( )

ÈÞ½Ä 03¿ù 09ÀÏ 204,5È£ 10:50~11:10 Coffee Break ( )

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 15:20~15:40 Pros for T3 + T4 combination À̽ÃÈÆ(°¡ÃµÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 15:40~16:00 Cons for T3 + T4 combination ±èº¸Çö(ºÎ»êÀÇ´ë ³»°ú)

±³À°½Ã°£ 03¿ù 09ÀÏ 204,5È£ 16:00~16:20 A Comprehensive overveiw of recent guidelines ±è´ÙÇÔ(¿¬¼¼ÀÇ´ë ³»°ú)

Åä·Ð 03¿ù 09ÀÏ 204,5È£ 16:20~16:30 Discussion ( )

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-03-09""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO °æÀÎÁöȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-03-09
´ÙÀ½±Û 2024³â ´ëÇÑ°©»ó¼±ÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-03-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
390 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø 2018³â ¾ÆÁÖ´ëÇб³ ¸¶ÃëÅëÁõÀÇÇаú Ãß°è Çмú´ëȸ : 2018-09-01 0 1,244 2018-08-15
389 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-09-01 0 578 2018-08-15
388 °æ³² â¿ø°æ»ó´ëÇб³º´¿ø 2018³â Áߺΰ泲 ¿¬¼ö±³À° : 2018-09-01 0 930 2018-08-15
387 °­¿ø Á¦19ȸ ´ëÇÑ Ã´Ãß¿Ü°úÇÐȸ ôÃßÅëÁõ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2018-09-01 0 864 2018-08-15
386 ºÎ»ê Á¦15ȸºÎ¿ï°æÇǺΰúÀÇ»çȸÇмú´ëȸ : 2018-09-01 0 1,079 2018-08-15
385 ¼­¿ï 2018 ¼­¿ï¾Æ»êº´¿ø À̺ñÀÎÈÄ°ú Ãß°è ÀÓ»ó ¿öÅ©¼¥ : 2018-09-01 0 767 2018-08-15
384 ´ëÀü ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ Á¤Çü¿Ü°úÁúȯ, ¼Õ»ó, Ä¡·á : 2018-09-01 0 1,472 2018-08-15
383 ¼­¿ï Preterm Birth International Collaborative Australasian(´ëÇÑ»êºÎÀΰúÇÐȸ&¼¼°èÁ¶»êÇÐȸ °øµ¿ÁÖ°ü) : 2018-08-31 0 1,136 2018-08-15
382 ¼­¿ï Çѱ¹Á÷¹«½ºÆ®·¹½ºÇÐȸ 2018³â ÇÏ°èÇмú´ëȸ : 2018-08-31 0 560 2018-08-15
381 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7Â÷ International Congress on Lipid Metabolism & Atherosclerosis (ICoLA 2018) : 2018-08-31 0 600 2018-08-15
380 ºÎ»ê ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ ºÎ»êÁöºÎÇÐȸ 8¿ù ¿ù·ÊÁý´ãȸ : 2018-08-30 0 1,256 2018-08-15
379 °­¿ø ¿øÁÖ ¼¼ºê¶õ½º ±âµ¶º´¿ø ±âÃʾȰúÁúȯ / CÇü °£¿° : 2018-08-29 0 2,246 2018-08-15
378 ¼­¿ï ´ëÇѼҾư¨¿°ÇÐȸ Á¦154Â÷ ¿ù·Ê¿¬¼ö°­ÁÂ(°¨¿°°ü¸® ¿¬¼ö±³À°) : 2018-08-28 0 630 2018-08-15
377 ¼­¿ï Á¦12ȸ ÁöµµÀü¹®ÀÇ Àü¹®ÇÐȸ(°¡Á¤ÀÇÇÐȸ) ±³À° : 2018-08-25 0 885 2018-08-15
376 ¼­¿ï Á¦13Â÷ ´ëÇѽŰæ¿Ü°úÇÐȸ ¼­¿ï°æÀÎ(°­¿ø-Á¦ÁÖ)Áöȸ : 2018-08-25 0 771 2018-08-15
1381 | 1382 | 1383 | 1384 | 1385 | 1386 | 1387 | 1388 | 1389 | 1390
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷